Montelukast and fluticasone significantly (P = 0.011) reduced peripheral blood eosinophil counts compared with salmeterol and fluticasone.
In patients with asthma or COPD a lesser degree of systemic exposure to inhaled fluticasone propionate has been observed.
This medicine contains the active ingredient fluticasone propionate, which is a type of medicine called a corticosteroid.
Information about this interaction is lacking for inhaled fluticasone propionate, but a marked increase in fluticasone propionate plasma levels is expected.
Fluticasone propionate (Flonase, Flovent) is reported to be helpful in most cases of EG, if the medicine is swallowed so that it comes directly in contact with the esophageal tissues that are infiltrated by eosinophils.